Arsenic-containing hydrocarbons and arsenic-containing fatty acids: Transfer across and presystemic metabolism in the Caco-2 intestinal barrier model

Molecular Nutrition and Food Research

Volumn 59, Issue 10, 2015, Pages 2044-2056

  Meyer, Sören ^a,b   Raber, Georg ^c   Ebert, Franziska ^b   Taleshi, Mojtaba S ^c   Francesconi, Kevin A ^c   Schwerdtle, Tanja ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Arsenolipids; Caco 2 intestinal barrier model; Presystemic metabolism; Toxicity

Indexed keywords

ARSENIC; FATTY ACID; HYDROCARBON;

BIOAVAILABILITY; CACO 2 CELL LINE; CHEMISTRY; DRUG EFFECTS; FOOD CONTAMINATION; HUMAN; INTESTINE ABSORPTION; METABOLISM; PERMEABILITY;

ARSENIC; BIOLOGICAL AVAILABILITY; CACO-2 CELLS; FATTY ACIDS; FOOD CONTAMINATION; HUMANS; HYDROCARBONS; INTESTINAL ABSORPTION; PERMEABILITY;

EID: 84942825245     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500286     Document Type: Article

References (49)

1. Francesconi, K. A., Arsenic species in seafood: origin and human health implications. Pure Appl. Chem. 2010, 85, 373-381.
2. Sele, V., Sloth, J. J., Lundebye, A. K., Larsen, E. H. et al., Arsenolipids in marine oils and fats: a review of occurrence, chemistry and future research needs. Food Chem. 2012, 133, 618-630.
3. Taleshi, M. S., Jensen, K. B., Raber, G., Edmonds, J. S. et al., Arsenic-containing hydrocarbons: natural compounds in oil from the fish capelin, Mallotus villosus. Chem. Commun. 2008, 4706-4707.
4. Rumpler, A., Edmonds, J. S., Katsu, M., Jensen, K. B. et al., Arsenic-containing long-chain fatty acids in cod-liver oil: a result of biosynthetic infidelity? Angew. Chem. Int. Ed. 2008, 47, 2665-2667.
5. Taleshi, M. S., Edmonds, J. S., Goessler, W., Ruiz-Chancho, M. J. et al., Arsenic-containing lipids are natural constituents of sashimi tuna. Environ. Sci. Technol. 2010, 44, 1478-1483.
6. Lischka, S., Arroyo-Abad, U., Mattusch, J., Kuhn, A. et al., The high diversity of arsenolipids in herring fillet (Clupea harengus). Talanta 2013, 110, 144-152.
7. Amayo, K. O., Raab, A., Krupp, E. M., Feldmann, J., Identification of arsenolipids and their degradation products in cod-liver oil. Talanta 2014, 118, 217-223.
8. Taleshi, M. S., Raber, G., Edmonds, J. S., Jensen, K. B. et al., Arsenolipids in oil from blue whiting Micromesistius poutassou - evidence for arsenic-containing esters. Sci. Rep. 2014, 4, 7492, 1-7.
9. Sele, V., Amlund, H., Berntssen, M. H., Berntsen, J. A. et al., Detection of arsenic-containing hydrocarbons in a range of commercial fish oils by GC-ICPMS analysis. Anal. Bioanal. Chem. 2013, 405, 5179-5190.
10. Garcia-Salgado, S., Raber, G., Raml, R. et al., Arsenosugar phospholipids and arsenic hydrocarbons in two species of brown macroalgae. Environ. Chem. 2012, 9, 63-66.
11. Raab, A., Newcombe, C., Pitton, D., Ebel, R. et al., Comprehensive analysis of lipophilic arsenic species in a brown alga (Saccharina latissima). Anal. Chem. 2013, 85, 2817-2824.
12. IARC, A review of human carcinogens. Part C: arsenic, metals, fibres, and dusts. IARC Monogr. 2012, 100, 196-211.
13. Meyer, S., Matissek, M., Muller, S. M., Taleshi, M. S. et al., In vitro toxicological characterisation of three arsenic-containing hydrocarbons. Metallomics 2014, 6, 1023-1033.
14. Meyer, S., Schulz, J., Jeibmann, A., Taleshi, M. S. et al., Arsenic-containing hydrocarbons are toxic in the in vivo model Drosophila melanogaster. Metallomics 2014, 6, 2010-2014.
15. Meyer, S., Raber, G., Ebert, F., Leffers, L. et al., In vitro toxicological characterisation of arsenic-containing fatty acids and three of their metabolites. Toxicol. Res. 2015, doi:10.1039/C5TX00122F
16. EFSA, EFSA Panel on Contaminants in the Food Chain (CONTAM); Scientific Opinion on Arsenic in Food. EFSA J. 2009, 7, 1351-1355.
17. Schmeisser, E., Goessler, W., Francesconi, K. A., Human metabolism of arsenolipids present in cod liver. Anal. Bioanal. Chem. 2006, 385, 367-376.
18. Schmeisser, E., Rumpler, A., Kollroser, M., Rechberger, G. et al., Arsenic fatty acids are human urinary metabolites of arsenolipids present in cod liver. Angew. Chem. Int. Ed. 2006, 45, 150-154.
19. Artursson, P., Borchardt, R. T., Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm. Res. 1997, 14, 1655-1658.
20. LeFerrec, E., Chesne, C., Artusson, P., Brayden, D. et al., In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods. Altern. Lab. Anim. 2001, 29, 649-668.
21. Shah, P., Jogani, V., Bagchi, T., Misra, A., Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol. Prog. 2006, 22, 186-198.
22. Taleshi, M. S., Seidler-Egdal, R. K., Jensen, K. B., Schwerdtle, T. et al., Synthesis and characterization of arsenolipids: naturally occurring arsenic compounds in fish and algae. Organometallics 2014, 33, 1397-1403.
23. Leffers, L., Wehe, C. A., Huwel, S., Bartel, M. et al., In vitro intestinal bioavailability of arsenosugar metabolites and presystemic metabolism of thio-dimethylarsinic acid in Caco-2 cells. Metallomics 2013, 5, 1031-1042.
24. Artursson, P., Karlsson, J., Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
25. Sambuy, Y., DeAngelis, I., Ranaldi, G., Scarino, M. L. et al., The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol. 2005, 21, 1-26.
26. Volpe, D. A., Variability in Caco-2 and MDCK cell-based intestinal permeability assays. J. Pharm. Sci. 2008, 97, 712-725.
27. Calatayud, M., Devesa, V., Montoro, R., Velez, D., In vitro study of intestinal transport of arsenite, monomethylarsonous acid, and dimethylarsinous acid by Caco-2 cell line. Toxicol. Lett. 2011, 204, 127-133.
28. Laparra, J. M., Velez, D., Barbera, R., Montoro, R. et al., Bioaccessibility and transport by Caco-2 cells of organoarsenical species present in seafood. J. Agric. Food Chem. 2007, 55, 5892-5897.
29. Leffers, L., Ebert, F., Taleshi, M. S., Francesconi, K. A., In vitro toxicological characterization of two arsenosugars and their metabolites. Mol. Nutr. Food Res. 2013, 57, 1270-1282.
30. Francesconi, K. A., Edmonds, J. S., Stick, R. V., Synthesis, NMR spectra and chromatographic properties of five trimethylarsonioribosides. Appl. Organomet. Chem. 1994, 8, 517-523.
31. Francesconi, K. A., Edmonds, J. S., A novel arsenical in clam kidney identified by liquid chromatography/electrospray ionisation mass spectrometry. Rapid Commun. Mass Spectrom. 2001, 15, 1641-1646.
32. Raber, G., Raml, R., Goessler, W., Francesconi, K. A., Quantitative speciation of arsenic compounds when using organic solvent gradients in HPLC-ICPMS. J. Anal At. Spectrom 2010, 25, 570-576.
33. Heinlein, A., Metzger, M., Walles, H., Buettner, A., Transport of hop aroma compounds across Caco-2 monolayers. Food Funct. 2014, 5, 2719-2730.
34. Hubatsch, I., Ragnarsson, E. G., Artursson, P., Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protoc. 2007, 2, 2111-2119.
35. Krishna, G., Chen, K., Lin, C., Nomeir, A. A., Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2. Int. J. Pharm. 2001, 222, 77-89.
36. Palmgren, J. J., Monkkonen, J., Korjamo, T., Hassinen, A. et al., Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions. Eur. J. Pharm. Biopharm. 2006, 64, 369-378.
37. Laparra, J. M., Velez, D., Barbera, R., Granero, L. et al., Cytotoxic effect of As(III) in Caco-2 cells and evaluation of its human intestinal permeability. Toxicol. In Vitro 2006, 20, 658-663.
38. McDermott, J. R., Jiang, X., Beene, L. C., Rosen, B. P. et al., Pentavalent methylated arsenicals are substrates of human AQP9. Biometals 2010, 23, 119-127.
39. Cooney, R. V., Mumma, R. O., Benson, A. A., Arsoniumphospholipid in algae. Proc. Natl. Acad. Sci. U S A 1978, 75, 4262-4264.
40. Sun, H., Chow, E. C., Liu, S., Du, Y.et al., The Caco-2 cell monolayer: usefulness and limitations. Expert Opin. Drug Metab. Toxicol. 2008, 4, 395-411.
41. Laparra, J. M., Vélez, D., Montoro, R., Barberá, R., Farré, R., Bioaccessibility of inorganic arsenic species in raw and cooked Hizikia fusiforme seaweed. Appl. Organomet. Chem. 2004, 18, 662-669.
42. Artursson, P., Palm, K., Luthman, K., Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 2001, 46, 27-43.
43. Lennernas, H., Human intestinal permeability. J. Pharm. Sci. 1998, 87, 403-410.
44. Lennernas, H., Human jejunal effective permeability and its correlation with preclinical drug absorption models. J. Pharm. Pharmacol. 1997, 49, 627-638.
45. Yee, S., In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - fact or myth. Pharm. Res. 1997, 14, 763-766.
46. Laparra, J. M., Velez, D., Barbera, R., Montoro, R. et al., An approach to As(III) and As(V) bioavailability studies with Caco-2 cells. Toxicol. In Vitro 2005, 19, 1071-1078.
47. Bartel, M., Ebert, F., Leffers, L., Karst, U. et al., Toxicological characterization of the inorganic and organic arsenic metabolite Thio-DMA in cultured human lung cells. J. Toxicol. 2011, 2011, 373141, 1-9.
48. Mass, M. J., Tennant, A., Roop, B. C., Cullen, W. R. et al., Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 2001, 14, 355-361.
49. US-EPA, Advisory on EPAs assessment of carcinogenic effects of organic and inorganic arsenic, US-EPA, Washington DC, 2007.